Abstract
It is accepted to distinguish several forms of malignant kidney tumors, the most frequent ones (85%) being hypernephroma or renal cell carcinoma originating from the cells of the renal parenchyma. Kidney sarcoma or Wilms’ tumor is observed exclusively in early childhood and is diagnosed in 90% of cases in children younger than 5 years old. Wilms’ tumor forms almost a half of all malignant tumors in children. Cancer of the renal pelvis originates from the epithelium of the renal pelvis and makes up 7% of all kidney tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aide N, Cappele O, Bottet P et al (2003) Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30:1236–1245
Bachor R, Kotzerke J, Gottfried HW (1996) Positron emission tomography in diagnosis of renal cell carcinoma [German]. Urologe A 35:146–150
Hoh C, Figlin R, Belldegrun A (1996) Evaluation of renal cell carcinoma with whole body FDG PET. J Nucl Med 37:141
Kang DE, White RL, Zuger JH et al (2004) Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 171:1806–1809
Kocher F, Grimmel S, Hautmann R et al (1994) Preoperative lymph node staging in patients with kidney and urinary bladder neoplasm. J Nucl Med 35(Suppl):233
Levine E (1995) Renal cell carcinoma: clinical aspects, imaging diagnosis, and staging. Semin Roentgenol 30:128–148
Poggi MM, Patronas N, Buttman JA (2001) Intramedullary spinal cord metastasis from renal cell carcinoma: detection by positron emission tomography. Clin Nucl Med 26:837–839
Ramdave S, Thomas GW, Berlangieri SU et al (2001) Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 166:825–830
Safaei A, Figlin R, Hoh CK et al (2002) The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for restaging of renal cell cancer. Clin Nephrol 57:56–62
Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292
Seto E, Segall GM, Terris MK (2000) Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan. Urology 55:286
Shreve PD, Miyauchi T, Wahl RL (1998) Characterization of primary renal cell carcinoma by FDG PET. Radiology 209:94
Wahl RL (1997) Clinical oncology update: the emerging role of PET: Part I. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, vol 11. Lippincott-Raven, Philadelphia, pp 1–18
Wahl RL, Harney J, Hutchins G et al (1991) Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies. J Urol 146:1470–1474
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Granov, A., Tiutin, L., Schwarz, T. (2013). Kidney Cancer. In: Granov, A., Tiutin, L., Schwarz, T. (eds) Positron Emission Tomography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21120-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-21120-1_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21119-5
Online ISBN: 978-3-642-21120-1
eBook Packages: MedicineMedicine (R0)